is tirzepatide considered a glp 1 The GLP-1 family, explained for researchers: Semaglutide, Tirzepatide, Retatrutide — what they are and the receptor research context. Note: Retatrutide investigational (Phase 3). No weight-loss or human-effect claims here — just The dual agonist action of
Description
To qualify for Semaglutide GLP-1 for weight loss, individuals must meet certain criteria and undergo a thorough medical evaluation
Compounded drugs are not FDA approved, and the semaglutide shortage-related enforcement-discretion periods ended in 2025

Wegovy, with a higher dose of semaglutide, offers even greater results, with average weight loss around 15-20% of body weight

J., Wells, S
